Is the Alternative Protein Market growing now?
In our alternative protein market deck, you will find everything you need to understand the market
SUMMARY
Yes, the Alternative Protein Market is growing now, but the growth is narrow, uneven, and coming from very different parts of the industry than during the 2020-2021 boom.
The global plant-based market has returned to modest expansion even while U.S. plant-based meat keeps shrinking. That split is the main reason the sector can look healthy in one dataset and broken in another.
Physical consumption matters more than headline sales here. Global plant-based meat and seafood volume grew about 3%, and total plant-based food volume across six major European markets rose roughly 4.8%, so the recent growth is not just inflation.
Europe is carrying much of the consumer recovery, but not through one uniform category. France is growing strongly in plant-based meat, while markets such as Germany are being helped more by milk, yogurt, tofu, tempeh and other formats.
Price is increasingly separating winners from losers. France and Italy combined lower plant-based meat prices with higher volumes, while several markets with rising prices saw volumes fall.
Plant-based dairy looks structurally healthier than plant-based meat. It already owns meaningful share of the milk category, has much deeper household penetration, and companies such as Oatly are still posting double-digit growth.
Fermentation is now the most commercially convincing part of next-generation alternative protein. The strongest companies are selling ingredients into existing food systems, winning real orders and expanding production without needing consumers to adopt an entirely new food brand.
Cultivated meat has crossed the line from laboratory concept to real product, but it is nowhere near becoming a meaningful volume driver. Regulatory approvals and restaurant launches are important milestones; the business still has to prove repeatable economics at scale.
Funding remains weak compared with both the boom years and the recent post-boom period. The capital that is still available is becoming more selective, with smaller rounds tied to manufacturing, customer delivery, regulatory work and concrete commercialization milestones.
The shutdowns are not random noise. They show that technical progress and even large production facilities were not enough to compensate for weak unit economics, limited demand or expensive scale-up.
The market is also changing what “winning” looks like. The old story centered on heavily funded consumer brands replacing conventional meat; the stronger opportunities now include cheaper plant-based formats, dairy alternatives, fermentation-derived ingredients and hybrid products that replace only part of an animal input.
The best description today is selective growth after a brutal reset. Enough consumption and commercial activity are improving to reject the idea that alternative protein is broadly dying, but the recovery is still far too uneven to call it a new boom.
This market map, featured in our alternative protein market deck, highlights top companies and startups in the alternative protein market
Why does alternative protein look like it is growing and dying at the same time?
The alternative protein market is growing in some important places today while shrinking badly in others, which is why completely opposite descriptions of the industry can both look credible.
Start with the two biggest consumer markets. U.S. plant-based meat and seafood retail sales fell 10% in dollars and 11% in units in 2025, according to SPINS data analyzed by the Good Food Institute. Only 11% of U.S. households bought the category, down from roughly 20% at its 2021 peak. Beyond Meat then reported another 8.2% revenue decline in its latest quarter, with product volume down 9.5%.
Cross the Atlantic and the picture changes. GFI Europe's latest Circana data show plant-based food volumes rising 13% in France, 6.2% in Germany, 5.8% in Italy and 6.6% in Spain. Beyond Meat itself grew international retail revenue 16.5% in its latest quarter, helped by stronger sales in Europe, the UK and Canada.
Newer technologies are separating too. Fermentation companies are getting products into Walmart, Target and mainstream dairy channels, while cultivated meat has regulatory approvals and a handful of restaurant launches but almost no market volume.
So we are dealing with several alternative protein markets moving at different speeds. The real question is whether the growing pieces are now large enough to pull the whole industry upward.
If you want more recent data on this point, please see our latest alternative protein market report.
What should actually count as growth in the alternative protein market?
Alternative protein is genuinely growing when people buy more of it, companies sell more of it and production expands because real demand requires it.
That sounds obvious, but alternative protein makes the distinction unusually important. A cultivated meat company receiving regulatory approval is progress. A fermentation company building a pilot plant is progress. A startup raising $20 million is progress. None of those events tells us whether consumers are buying more protein alternatives.
For plant-based products, we already have retail sales, physical volumes, household penetration, repeat purchasing and foodservice data. Those deserve the most weight.
Fermentation and cultivated meat are earlier. We have to look at commercial orders, retail distribution, production volumes and partnerships because industry-wide revenue data barely exist. Even there, a product appearing in one restaurant is very different from a product generating repeat orders across thousands of stores.
Funding deserves a separate treatment. More investment can accelerate future growth, but the 2020-2021 alternative protein boom showed why venture dollars cannot substitute for customer demand.
Our test is simple: sales and physical consumption come first, commercial scale comes second, and funding or technical milestones help us judge where the market could go next.
As this chart shows, and as featured in our alternative protein market deck, search interest in pea protein has been growing steadily
Are global alternative protein sales actually growing today?
Global plant-based food sales are growing today, although the pace is much closer to steady expansion than another alternative protein boom.
According to GFI's 2026 analysis of Euromonitor data, worldwide retail sales across plant-based meat, seafood, milk, yogurt, ice cream and cheese reached an estimated $28.9 billion in 2025, up 3% from the previous year.
Plant-based meat and seafood reached about $6.6 billion globally. Looking beyond inflation makes that number more interesting: GFI's analysis indicates roughly 8% nominal sales growth, around 4% inflation-adjusted growth and approximately 3% growth in physical sales volume.
That last number is the useful one. Global plant-based meat consumption actually increased despite the large U.S. decline.
Europe explains much of the gap. Europe and North America together still account for more than 80% of global plant-based meat and seafood sales, so Europe is large enough to offset weakness elsewhere when several European markets grow at once.
Global alternative protein demand has therefore stopped looking like a simple post-boom collapse. The broad plant-based market is expanding again, just at a modest pace and with a very uneven geographic mix.
| Market | Latest sales | Latest movement | What we see |
|---|---|---|---|
| Global plant-based food across six major categories | $28.9B | +3% | Broad market still expanding |
| Global plant-based meat and seafood | $6.6B | About +8% nominal | Growth returned globally |
| Global plant-based meat and seafood volume | — | About +3% | Growth goes beyond inflation |
| U.S. plant-based foods | $7.9B | -2% dollars, -3% units | U.S. remains weak |
| U.S. plant-based meat and seafood | $1.0B | -10% dollars, -11% units | Biggest visible problem area |
Why is U.S. plant-based meat still falling?
U.S. plant-based meat is still shrinking badly, and the latest data give us little reason to call a recovery yet.
The category lost another 10% of retail sales and 11% of units in 2025. Conventional meat and seafood units grew 1% over the same period. In foodservice, plant-based protein pound sales fell 5%, while analog meat and seafood fell 11%.
The customer data are even harder to dismiss. Plant-based meat reached roughly 20% of American households in 2021. By 2025, penetration had fallen to 11%. Retail distribution also contracted, and mainstream unit velocity fell another 4%.
The remaining customers seem fairly loyal. Around 62% of households that bought plant-based meat purchased it more than once, and units per buyer stayed around 11.7. The problem sits largely at the edge of the customer base: too many people tried the category and stopped coming back.
Those customers also remain overwhelmingly meat eaters. Among U.S. households buying plant-based meat, 96% bought conventional meat as well. They averaged roughly six plant-based meat purchase occasions during the year versus 33 conventional meat occasions.
Beyond Meat gives us a live company-level check. Its latest quarter produced $68.8 million of revenue, down 8.2%, with volume down 9.5%. U.S. retail revenue fell 9.9%, while U.S. foodservice revenue dropped 27.6%. For the first half of 2026, total company revenue was down 11.6%.
There are some healthier corners. Shreds, chunks and strips grew 8% in U.S. retail units during 2025, and flavored products performed better than the category average. Beyond Meat's international retail business is also growing. Those pockets have yet to change the American category's direction.
This chart, featured in our alternative protein market deck, shows annual venture capital investment in alternative protein startups
Is Europe now keeping plant-based food growth alive?
Europe is doing much of the heavy lifting for plant-based food growth right now, with France, Germany, Italy and Spain all increasing physical consumption.
We combined GFI Europe's latest Circana figures for France, Germany, Italy, the Netherlands, Spain and the UK. Plant-based food sales across those six markets rose from about €4.60 billion to €4.75 billion in one year, an increase of roughly 3.3%.
Volume grew faster, from around 1.50 billion kilograms to 1.57 billion kilograms, or about 4.8%. That is a better sign than revenue growth alone because consumers physically bought more food.
France stands out. Total plant-based volume jumped 13%, while plant-based meat volume increased 16.8%. Germany remains the largest market at €1.71 billion and grew 6.2% in total volume. Italy added 5.8%, while Spain grew 6.6%.
The UK and Netherlands are still struggling, with total volumes down 2.5% and 1.3% respectively. Plant-based meat is weaker than the broader market too. German meat-alternative volume slipped 1.7%, while Spain, the Netherlands and the UK recorded much larger declines.
Europe's growth is becoming broader than imitation burgers. Milk, yogurt, tofu, tempeh and other categories are increasingly carrying the market when plant-based meat slows.
| Country | Plant-based sales | Total volume change | Plant-based meat volume change |
|---|---|---|---|
| France | €572M | +13.0% | +16.8% |
| Germany | €1.71B | +6.2% | -1.7% |
| Italy | €669M | +5.8% | +4.1% |
| Netherlands | €259M | -1.3% | -10.7% |
| Spain | €546M | +6.6% | -7.0% |
| United Kingdom | €993M | -2.5% | -9.4% |
Is price deciding which plant-based meat markets grow?
Price appears to be one of the strongest reasons plant-based meat grows in one European country and shrinks in another.
France gives us the cleanest example. Average plant-based meat prices fell 2.8% while sales volume jumped 16.8%. Italy saw prices fall 2% and volume rise 4.1%.
The pattern flips in Germany, Spain and the UK. German prices increased 2% and volume slipped 1.7%. Spanish prices rose 0.7% while volume dropped 7%. UK prices rose 2.3% while volume fell 9.4%.
The Netherlands adds another useful comparison. Plant-based meat volumes dropped 10.7%, while tofu, tempeh and seitan grew almost 30%. GFI Europe found that tofu cost roughly one-third as much as branded plant-based meat there.
Price alone cannot explain everything. Dutch consumers still bought 3.6 times more plant-based meat than tofu, tempeh and seitan combined, even with the huge price difference. In the UK, some expensive oat and barista milks continued to perform well. People will pay more when they really like the product.
Still, the broad pattern is hard to miss. A plant-based product that costs substantially more and tastes merely "good enough" has a difficult path to mainstream growth. France currently shows what can happen when that equation improves.
| Country | Plant-based meat price change | Volume change |
|---|---|---|
| France | -2.8% | +16.8% |
| Italy | -2.0% | +4.1% |
| Germany | +2.0% | -1.7% |
| Spain | +0.7% | -7.0% |
| Netherlands | +0.3% | -10.7% |
| United Kingdom | +2.3% | -9.4% |
If you want more recent data on this point, please see our latest alternative protein market report.
This chart, featured in our alternative protein market deck, looks at Impossible Foods’ strategy in alternative protein
Is plant-based dairy doing much better than plant-based meat?
Plant-based dairy has built a much stronger consumer market than plant-based meat, even though dairy alternatives are not growing everywhere.
The easiest comparison is market share. Plant-based milk still represented around 13% of U.S. milk retail dollars in 2025. Plant-based meat represented just 1.4% of packaged meat sales and about 0.7% once random-weight conventional meat is included.
European penetration is similarly substantial. Plant-based milk now accounts for roughly 7% to 10% of all milk sold in Germany, Italy, Spain and the Netherlands. Almost half of Spanish households bought plant-based milk in 2025, while 38% of German households did.
Oatly's latest results show that meaningful company growth is still possible here. Revenue increased 15.2% year over year to $240.1 million in the second quarter of 2026. Even after removing the currency benefit, revenue increased 12.7%, while liters sold rose 11.2%.
Compare that with Beyond Meat's 8.2% revenue decline and 9.5% volume decline over a similar reporting period. The divergence is becoming difficult to treat as a temporary company-specific issue.
U.S. plant-based milk still fell 2% in dollars and 5% in units during 2025, so the category has its own slowdown. Its deeper household penetration, much larger animal-category share and everyday use in coffee, cereal and drinks give it a far stronger base from which to recover.
Is fermentation now the strongest part of alternative protein?
Fermentation currently has the best combination of fresh funding, commercial orders and real product launches anywhere in next-generation alternative protein.
GFI counted more than 163 specialized fermentation companies active in 2025. Commercial-scale facilities opened in Brazil, Canada, China, Sweden and the UK, while new products appeared across meat, dairy, egg and ingredient applications.
The stronger evidence is coming from customers. The EVERY Company said orders secured for its precision-fermented OvoPro egg protein during the first four months of 2026 were equivalent to 550% of its entire 2025 order volume. The company is quadrupling manufacturing output as OvoPro moves into products sold through Walmart and Target.
Other companies are finding conventional distribution partners rather than building alternative-protein brands from scratch. Imagindairy's whey protein has gone into dairy-free products sold by Strauss Group. Remilk has worked with established dairy producer Gad Dairies. Planetary's mycoprotein reached Aldi Suisse through private label, while fermentation-enabled products from Planted have expanded through European retail.
Capital is following that commercial progress. GFI's live investment tracker shows fermentation companies raising $132 million in the second quarter of 2026, compared with $41 million for plant-based companies and $25 million for cultivated meat companies. Fermentation therefore captured about two-thirds of the money invested across the three technology pillars that quarter.
The model is changing too. Many of the more interesting fermentation companies sell proteins, fats or functional ingredients to food manufacturers rather than asking consumers to fall in love with another startup brand. That gives them more ways to win.
Fermentation still has expensive scale-up problems and plenty of failed companies. For now, though, it is where alternative protein's commercial momentum looks strongest.
If you want more recent data on this point, please see our latest alternative protein market report.
This chart, featured in our alternative protein market deck, shows annual funding in alternative protein startups
Is cultivated meat finally becoming a real business?
Cultivated meat is becoming a real product today, but sales remain far too small for the segment to count as a meaningful growth engine for alternative protein.
The industry has crossed several barriers that used to look formidable. Cultivated products have been cleared for sale in Singapore, the United States and Australia. Wildtype cultivated salmon is now being served in several U.S. restaurants and was added to José Andrés' barmini in Washington in 2026. Mission Barns has sold products containing cultivated pork fat in restaurants and through a limited U.S. grocery launch.
Production technology is progressing as well. PARIMA said in July 2026 that it produced cultivated duck at multi-tonne scale in a single 22,000-liter run with Vow and had cut production costs by 99% compared with its earlier runs. That is a company-reported result rather than independent proof of industry-wide economics, but the scale is worth watching.
The commercial reality remains tiny. A few restaurants, tastings and limited grocery sales barely register beside a global meat industry producing hundreds of millions of tonnes per year.
Believer Meats shows how large the gap can be between technological progress and a functioning business. The company completed a 200,000-square-foot U.S. production facility, received regulatory clearance for cultivated chicken and then ceased operations in late 2025 amid a cash crunch and a dispute involving more than $34 million in construction bills.
Cultivated meat has moved beyond lab demos. We still have almost no evidence that the economics work at mass-market scale.
Is alternative protein funding recovering in 2026?
Alternative protein funding has not recovered yet: investors are still putting much less money into the sector than they did during either the boom years or the recent post-boom period.
GFI's latest live investment tracker puts total alternative protein funding at $359 million for the first half of 2026. The industry raised $881 million during all of 2025 and roughly $1.1 billion in 2024.
Even a mechanical doubling of the first-half figure would produce about $718 million for the year. Funding is lumpy, so we would never treat that as a forecast, but it shows how far the current pace sits below 2025.
The gap with the boom years is much wider. Around $5 billion flowed into alternative protein companies in 2021. GFI has since changed data providers and refined its methodology, which makes an exact apples-to-apples comparison difficult, but the order of magnitude is clear.
Where the money goes has changed too. Fermentation received $132 million in the second quarter of 2026, while plant-based companies raised $41 million and cultivated meat companies $25 million. Investors are rewarding technologies and businesses that can show a clearer route toward production economics and customer orders.
Our own narrower funding tracker, which uses a different inclusion methodology, found around $138 million across the latest 12 disclosed financings. Those deals included venture equity alongside grants, credit and crowdfunding, so we keep that number separate from GFI's market-wide investment total.
Investors are still interested in alternative protein these days. They have simply become much harder to convince.
This chart, featured in our alternative protein market deck, compares the main business model options for alternative protein brands
Are alternative protein startups raising smaller rounds now?
Alternative protein startups are getting financed more selectively now, with many recent rounds sized for another stage of commercialization rather than huge factory bets.
Our tracker counted 35 qualifying disclosed financings worth about $492 million across five consecutive quarters from the second quarter of 2025 through the second quarter of 2026.
Deal count increased from three in the first quarter of that window to ten in the latest one. Average check size moved in the opposite direction after a few large rounds temporarily inflated the numbers. The third quarter of 2025 produced roughly $153 million from only four deals, or about $38 million each. By the second quarter of 2026, ten tracked deals represented roughly $102 million, averaging close to $10 million.
The latest financing announcements also tell us what investors want the money used for. Standing Ovation has been scaling fermentation-derived casein. Planetary has been expanding fermentation manufacturing. NS/TX Industries raised financing around automated production of structured plant proteins. StrainX is working on lower-cost precision-fermentation manufacturing.
Much of today's capital is paying for scale-up, regulatory work, customer delivery and better manufacturing economics. The market has fewer giant promises and more milestones that companies have to hit before the next check arrives.
| Quarter | Tracked deals | Disclosed capital | Average tracked round |
|---|---|---|---|
| Q2 2025 | 3 | about $14M | about $4.7M |
| Q3 2025 | 4 | about $153M | about $38.2M |
| Q4 2025 | 9 | about $119M | about $13.2M |
| Q1 2026 | 9 | about $105M | about $11.7M |
| Q2 2026 | 10 | about $102M | about $10.2M |
Are all these alternative protein shutdowns a bad sign?
The alternative protein shakeout is a clear sign that the previous business model funded too many companies ahead of real demand, even though the surviving industry may eventually come out stronger.
GFI counted at least 19 plant-based companies that were acquired or bought out during 2025. Other businesses shut down, restructured or sold assets after struggling to finance continued operations.
Meati became one of the best examples. After raising hundreds of millions of dollars for mycelium-based meat, the company's previous owner entered an Assignment for the Benefit of Creditors process in 2025. Its assets later moved to a new owner following layoffs and severe cash pressure.
Cultivated meat has produced an even sharper example with Believer Meats. The company had raised more than $390 million according to CTech, built a huge production facility and cleared major U.S. regulatory hurdles before running out of money and ceasing operations.
These failures tell us more than another small startup disappearing. Both companies had advanced technology, substantial capital and real production infrastructure. They still struggled to bridge the distance between "we can manufacture this food" and "we can manufacture enough of it profitably."
The industry is now being forced to prove that second part much earlier. That is painful for company counts and employment today, but it also removes one of the biggest distortions from the boom years: money is no longer available simply because a company can tell a convincing story about replacing meat someday.
If you want more recent data on this point, please see our latest alternative protein market report.
This chart, featured in our alternative protein market deck, shows revenue breakdown by customer segment in the alternative protein market
Is alternative protein actually taking market share from conventional meat?
Alternative protein is taking meaningful share in a few categories such as milk, but it is barely denting conventional meat consumption today.
In U.S. retail, plant-based meat and seafood represented roughly 1.4% of packaged meat dollar sales in 2025 and around 0.7% of total meat once random-weight products are included. Conventional meat units grew 1% that year while plant-based meat units fell 11%.
Plant-based milk has gone much further, reaching 13% of U.S. milk dollars and around 7% to 10% of milk volumes in several large European countries. That shows alternative proteins can take substantial category share when the product works well, costs become reasonable and the usage habit is easy.
Globally, animal protein keeps expanding. The OECD-FAO Agricultural Outlook estimates meat production at roughly 375 million tonnes in 2025 and expects global meat consumption to reach around 412 million tonnes by 2035, with poultry supplying much of the additional demand.
That scale puts today's $6.6 billion plant-based meat market into perspective. Alternative meat can become a large business without conventional meat consumption falling, especially as global food demand keeps rising.
The more realistic competition right now happens product by product. Oat milk can take a coffee occasion. Fermentation-derived egg protein can replace egg white inside a packaged food. Cultivated fat can improve a hybrid meatball. Each substitution can grow into a useful market long before alternative protein replaces a meaningful share of global livestock production.
What would make the alternative protein market clearly grow again?
Alternative protein would look like an obvious growth market again if consumer penetration, sales volume and production economics started improving together rather than in isolated pockets.
U.S. plant-based meat gives us the easiest benchmark. Household penetration has to stop falling from 11% and begin recovering. Existing customers also need to buy the products more often: current buyers average roughly six plant-based meat shopping occasions per year versus 33 for conventional meat.
Price gaps need to keep closing. France has already shown what can happen when plant-based meat becomes cheaper and physical demand responds. Germany's private-label plant-based milk gives another example: those products are now cheaper than private-label dairy milk despite an unfavorable tax rate, and German plant-based milk volume grew 7.7%.
Retailers then need to see higher sales per shelf position. U.S. plant-based meat distribution and mainstream velocity are both falling. A credible recovery would eventually reverse both numbers.
For fermentation, the benchmark is recurring industrial demand. EVERY's 550% jump in contracted order volume and move into Walmart and Target is exactly the sort of evidence we want to see repeated by several companies.
Cultivated meat faces the hardest test. The industry has to turn successful production runs into food that can be manufactured repeatedly, sold at workable margins and distributed far beyond high-end restaurants.
Once several of those trends move together, we can stop debating whether alternative protein is recovering. The growth will show up directly in what consumers buy and what producers can profitably make.
This chart, featured in our alternative protein market deck, shows how plant-based meat product technology has evolved over time
So, is the Alternative Protein Market growing now?
Yes, but only partly: the Alternative Protein Market is growing now at the global sales level, while several of its biggest former growth engines are still shrinking.
The strongest evidence for growth comes from actual consumption. Global plant-based food retail sales reached an estimated $28.9 billion and increased 3%. Global plant-based meat and seafood volume grew around 3%. Across six major European markets, the latest data show total plant-based food volume growing roughly 4.8%. France, Germany, Italy and Spain all increased physical consumption.
Fermentation adds a second source of momentum. Products are reaching mainstream retail, commercial orders are rising at companies such as EVERY, and fermentation captured about two-thirds of investment across the three alternative protein technology pillars in the latest quarter reported by GFI.
The weak side remains substantial. U.S. plant-based meat units fell 11%. Household penetration has dropped from roughly 20% in 2021 to 11%. Beyond Meat's latest revenue and volumes are still falling. Alternative protein companies raised only $359 million during the first half of 2026, leaving funding far below its previous levels. Cultivated meat has reached real customers but contributes almost nothing to overall food volumes.
The shape of the market has changed. Growth is coming from Europe, plant-based dairy, cheaper formats, fermentation-derived ingredients and a smaller group of companies that can show actual customer demand. The old thesis of heavily funded consumer brands quickly replacing conventional meat has lost a lot of credibility.
We therefore see an alternative protein market that is growing again, but narrowly and unevenly. Calling it a new boom would be wrong. Calling the whole market a dying category now misses the global sales growth, the European volume data and the commercial progress in fermentation.
For now, "selective growth after a brutal reset" is the closest description of what is actually happening.
If you want more recent data on this point, please see our latest alternative protein market report.
OUR METHODOLOGY
This analysis tests whether the Alternative Protein Market is actually growing now by separating the industry into the dimensions that best reveal its current direction: consumer demand, geographic performance, category dynamics, pricing, commercial scale, investment, and competition with conventional protein.
We gave the most weight to indicators closest to real market activity. Physical sales volumes, household penetration, purchase frequency, retail sales and company revenue therefore matter more here than funding announcements, regulatory milestones or new product launches on their own.
For plant-based products, the evidence is relatively mature, so we compare sales with physical volumes, household behavior and foodservice activity. That helps distinguish real consumption growth from price increases and makes the U.S.-Europe divergence much easier to see.
For fermentation and cultivated meat, comprehensive market-wide revenue data barely exist. We therefore use commercial orders, mainstream distribution, production expansion, regulatory clearance and products reaching paying customers as evidence of progression, while keeping a clear distinction between a limited launch and repeat business at scale.
We kept funding separate from demand. Investment can accelerate future growth, but the 2020-2021 boom showed that large financing rounds do not prove that consumers are buying more alternative protein or that production economics work.
We also avoided averaging away contradictions. When sales, volumes, prices, company results or geographic markets moved in different directions, we kept those differences visible because the divergence itself is often the most useful explanation of what is happening.
Our narrower financing tracker is treated separately from GFI's market-wide investment totals because the inclusion rules differ. It combines disclosed financings such as venture equity, grants, credit and crowdfunding, so it is useful for understanding deal size and financing behavior rather than as a substitute for an industry-wide capital total.
The final conclusion is not produced by a mechanical score or a single market-size estimate. We assess each dimension according to how directly it demonstrates real demand or commercial scale, then look at what the strongest recent evidence shows collectively. That is why we describe the market as experiencing selective growth after a brutal reset rather than either a broad collapse or a new boom.
Key sources used for this analysis include: https://gfi.org/resource/plant-based-meat-eggs-and-dairy-state-of-the-industry/, https://gfi.org/marketresearch/, https://gfi.org/resource/analyzing-plant-based-meat-and-seafood-sales/, https://gfieurope.org/european-plant-based-sales-data/, https://investors.beyondmeat.com/news-releases/news-release-details/beyond-meatr-reports-second-quarter-2026-financial-results-0/, https://investors.oatly.com/news-releases/news-release-details/oatly-reports-second-quarter-2026-financial-results, https://gfi.org/resource/fermentation-meat-seafood-eggs-dairy-and-ingredients-state-of-the-industry/, https://gfi.org/investment/, https://hfpappexternal.fda.gov/scripts/fdcc/index.cfm?set=animalcellculturefoods, https://www.foodstandards.gov.au/food-standards-code/applications/A1269-Cultured-Quail-as-a-Novel-Food, https://www.wildtypefoods.com/news, https://missionbarns.com/usda-clearance/, https://parima.bio/blog/parima-demonstrates-ton-scale-cultivated-meat-production-at-viable-unit-economics, and https://www.oecd.org/en/publications/oecd-fao-agricultural-outlook-2026-2035_47874669-en/full-report/meat_149b4ca3.html.
In our alternative protein market deck, we identify pain points entrepreneurs should prioritize
Related blog posts
